Maze Therapeutics (MAZE) Misses Q4 EPS by 65c
Tweet
Share
E-mailGet Alerts MAZE Hot Sheet
Join SI Premium – FREE
Maze Therapeutics (NASDAQ: MAZE) reported Q4 EPS of ($0.65).
For earnings history and earnings-related data on Maze Therapeutics (MAZE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Bread Financial reports lower loss, delinquency rates in July 2026
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
